Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum

Journal of Periodontology

Volumn 75, Issue 3, 2004, Pages 429-440

  Anusaksathien, Orasa ^a   Jin, Qiming ^a   Zhao, Ming ^a   Somerman, Martha J ^a,b   Giannobile, William V ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cementogenesis; Dental cementum; Green flourescent; Growth factors; Platelet derived; Protein

Indexed keywords

GREEN FLUORESCENT PROTEIN; OSTEOCALCIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ANTAGONIST; POLYMER; PROTEIN INHIBITOR; SIALOPROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMINERALIZATION; CELL DENSITY; CELL IMMORTALIZATION; CELL STIMULATION; CELL TRANSPLANTATION; CEMENTUM; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; GIANT CELL; INHIBITION KINETICS; MINERALIZATION; MORPHOMETRICS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERIODONTAL LIGAMENT; PERIODONTITIS; PERIODONTIUM; PROMOTER REGION; SCID MOUSE; SIMIAN VIRUS 40; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SECTION; TOOTH DEVELOPMENT; TOOTH ROOT; TRANSGENIC MOUSE; TREATMENT OUTCOME; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL COUNT; CELL LINE; CEMENTOGENESIS; DENTAL CEMENTUM; DOWN-REGULATION; GENE TRANSFER TECHNIQUES; GIANT CELLS; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LACTIC ACID; LUMINESCENT PROTEINS; MICE; MICE, SCID; MICE, TRANSGENIC; OSTEOCALCIN; OSTEOPONTIN; PLATELET-DERIVED GROWTH FACTOR; POLYGLYCOLIC ACID; POLYMERS; SIALOGLYCOPROTEINS; SIMIAN VIRUS 40; TISSUE ENGINEERING;

EID: 1842738498     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.3.429     Document Type: Article

References (57)

1. Saygin NE, Giannobile WV, Somerman MJ. Molecular and cell biology of cementum. Periodontol 2000 2000;24: 73-98.
2. Lynch SE, de Castilla GR, Williams RC, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991;62:458-467.
3. Chai Y, Bringas P Jr, Mogharei A, Shuler CF, Slavkin HC. PDGF-A and PDGFR-alpha regulate tooth formation via autocrine mechanism during mandibular morphogenesis in vitro. Dev Dyn 1998;213:500-511.
4. Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD. Platelet alpha granules contain a growth factor for fibroblasts. Blood 1979;53:1043-1052.
5. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 1982;92:584-588.
6. Heldin P, Laurent TC, Heldin CH. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989;258:919-922.
7. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401: 86-90.
8. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998;1378:F79-F113.
9. Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodontal Res 1992;27:285-290.
10. Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: Results following a single administration of PDGF/IGF-I. J Periodontol 1994;65: 1158-1168.
11. Giannobile WV, Hernandez RA, Finkelman RD, et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 1996;31:301-312.
12. Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.
13. Anusaksathien O, Giannobile WV. Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol 2002;3:129-139.
14. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci (USA) 1996;93:5753-5758.
15. Eriksson E, Yao F, Svensjo T, et al. In vivo gene transfer to skin and wound by microseeding. J Surg Res 1998; 78:85-91.
16. Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003;74:202-213.
17. Zhu Z, Lee CS, Tejeda KM, Giannobile WV. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res 2001; 80:892-897.
18. Giannobile WV, Lee CS, Tomala MP, Tejeda KM, Zhu Z. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 2001;72:815-823.
19. Chen Q-P, Giannobile WV. Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalphaR and prolongs ERK and Akt/PKB activation. Am J Physiol Cell Physiol 2002;282:C538-544.
20. Anusaksathien O, Webb SA, Jin Q-M, Giannobile WV. PDGF gene delivery stimulates ex vivo gingival wound repair. Tissue Eng 2003;9:745-756.
21. Jin QM, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004;in press.
22. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029-1034.
23. Yang XB, Roach HI, Clarke NM, et al. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001;29:523-531.
24. Ishaug SL, Crane GM, Miller MJ, et al. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
25. Shea LD, Wang D, Franceschi RT, Mooney DJ. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 2000;6: 605-617.
26. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402.
27. Mattson JS, Gallagher SJ, Jabro MH. The use of 2 bioabsorbable barrier membranes in the treatment of interproximal intrabony periodontal defects. J Periodontol 1999;70:510-517.
28. Sigurdsson TJ, Nygaard L, Tatakis DN, et al. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
29. Jin QM, Zhao M, Webb SA, et al. Cementum engineering using three-dimensional polymer scaffolds. J Biomed Mater Res 2003;67A:54-60.
30. Zhao M, Jin QM, Berry JE, Nociti FH Jr., Giannobile WV, Somerman MJ. Cementoblast delivery for periodontal tissue engineering. J Periodontol 2004;75:154-161.
31. D'Errico JA, Ouyang H, Berry JE, et al. Immortalized cementoblasts and periodontal ligament cells in culture. Bone 1999;25:39-47.
32. Mooney DJ, Sano K, Kaufmann PM, et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 1997;37:413-420.
33. Murphy WL, Dennis RG, Kileny JL, Mooney DJ. Salt fusion: An approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 2002; 8:43-52.
34. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-167.
35. Young MF, Kerr JM, Termine JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990;7:491-502.
36. Young MF, Ibaraki K, Kerr JM, Lyu MS, Kozak CA. Murine bone sialoprotein (BSP): CDNA cloning, mRNA expression, and genetic mapping. Mamm Genome 1994; 5:108-111.
37. Pierce GF, Mustoe TA, Lingeibach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-440.
38. Jiranek WA, Machado M, Jasty M, et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 1993;75: 863-879.
39. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997;12:32-42.
40. Pinheiro M-LB, Feres-Filho EJ, Graves DT, et al. Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients. J Periodontol 2003;74:323-328.
41. Zhang Z, Chen J, Jin D. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: The role of receptor beta. Biochem Biophys Res Commun 1998;251:190-194.
42. Kubota K, Sakikawa C, Katsumata M, Nakamura T, Wakabayashi K. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J Bone Miner Res 2002;17:257-265.
43. Saygin NE, Tokiyasu Y, Giannobile WV, Somerman MJ. Growth factors regulate expression of mineral associated genes in cementoblasts. J Periodontol 2000;71:1591-1600.
44. Hsieh SC, Graves DT. Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory. J Cell Biochem 1998;69:169-180.
45. Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 2002;71:145-154.
46. Giachelli CM, Steitz S. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol 2000;19:615-622.
47. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998;152:353-358.
48. Pierce GF, Mustoe TA, Lingelbach J, et al. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci (USA) 1989;86:2229-2233.
49. Yu X, Hsieh SC, Bao W, Graves DT. Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am J Physiol 1997;272:C1709-1716.
50. Ogata Y, Niisato N, Furuyama S, et al. Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: Identification of a TGF-beta activation element in the rat BSP gene promoter. J Cell Biochem 1997; 65:501-512.
51. Chaudhary LR, Avioli LV. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: Differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 1997; 238:134-139.
52. Lai CF, Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 2002;277:15514-15522.
53. Mercola M, Deininger PL, Shamah SM, et al. Dominant-negative mutants of a platelet-derived growth factor gene. Genes Dev 1990;4:2333-2341.
54. Shamah SM, Stiles CD, Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol 1993;13:7203-7212.
55. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci (USA) 1993;90: 8562-8565.
56. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996;317:59-64.
57. Bronckers AL, Price PA, Schrijvers A, Bervoets TJ, Karsenty G. Studies of osteocalcin function in dentin formation in rodent teeth. Eur J Oral Sci 1998;106:795-807.